Keratoprosthesis Indications, Outcomes, and Future Directions
Access to this document is restricted. Some items have been embargoed at the request of the author, but will be made publicly available after the "No Access Until" date.
During the embargo period, you may request access to the item by clicking the link to the restricted file(s) and completing the request form. If we have contact information for a Cornell author, we will contact the author and request permission to provide access. If we do not have contact information for a Cornell author, or the author denies or does not respond to our inquiry, we will not be able to provide access. For more information, review our policies for restricted content.
PURPOSE: To provide a comprehensive review of keratoprosthesis (KPro), emphasizing the Boston KPro's development, design, surgical techniques, complications, and outcomes, while highlighting unresolved challenges and future research directions. METHODS: A narrative literature review was conducted to examine the evolution of KPro, assess commonly used artificial corneas, and analyze current technologies. Specific emphasis was placed on the Boston Keratoprosthesis. RESULTS: The review identified key areas for improvement in Boston KPro, including enhancement of titanium backplates to reduce retroprosthetic membrane formation, better adhesion between the corneal graft and backplate, and refinement of donor graft preparation to prevent corneal melting. Challenges in glaucoma monitoring because of unreliable intraocular pressure measurements were noted. Adjunctive strategies such as optimized vancomycin use, antifungal prophylaxis, drug-releasing contact lenses, and biologic therapies were explored. Cost-containment and accessibility issues were also addressed, along with emerging innovations in KPro design. CONCLUSIONS: Keratoprosthesis represents a viable alternative for patients unsuitable for traditional corneal transplantation. Ongoing research into surgical techniques, material science, prophylaxis, and design improvements will be critical to enhancing patient outcomes, minimizing complications, and expanding global access to KPro.